Oslo Cancer Cluster and French partner Cancer-Bio-Santé are joining forces with SwedenBio to offer the global Life Science industry the largest partnering conference in the Nordics – Nordic Life Science Days featuring the 6th European Cancer Cluster Partnering. Already now oncology biotechs, early stage companies and academics may submit an application for presenting at NLSDays-ECCP […]
The Norwegian Research Council recently granted BerGenBio, PCI Biotech, Lytix Biopharma, Oncoinvent and Ultimovacs – all Oslo Cancer Cluster member companies – funding through the Programme for User-Driven Research Based Innovation (BIA). In total, the Research Council will grant a record amount of 444 million to 58 Norwegian companies over four years, of which 10 are […]
The Norwegian Research Council recently granted BerGenBio, PCI Biotech, Lytix Biopharma, Oncoinvent and Ultimovacs – all Oslo Cancer Cluster member companies – funding through the Programme for User-Driven Research Based Innovation (BIA). In total, the Research Council will grant a record amount of 444 million to 58 Norwegian companies over four years, of which 10 are […]
Friday January 31 Oslo Cancer Cluster, SINTEF, NTNU, Oslo University Hospital and the Norwegian Cancer Society invite Norwegian media and other interested parties to join a breakfast seminar on nano cancer medicine. The seminar is held in conjunction with 12 similair events across the whole of Europe in relation to Nano World Cancer Day. Below […]
